Loading ...

EVR and EPO for Liver Transplant Tolerance

(

EVEREST

)

ITN Protocol #:

ITN101ST

Branded Name:

EVEREST

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Development

Summary:

Everolimus and Epoetin for Sustained liver transplant Tolerance

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Scientist

Study Personnel:

Protocol Chair

Michele DesMaraismdesmarais@immunetolerance.org

Work: 

415-420-4250

Protocol Chair

Emerson Sosaesosa@immunetolerance.org

Work: 

415-218-7981

Protocol Chair

Cynthia Breeden, MPHcbreeden@immunetolerance.org

Work: 

404-379-5811

Protocol Chair

Sindhu Chandran, MDschandran@immunetolerance.org

Work: 

415-610-4284

Protocol Chair

Merideth Brown Shifflettbrownmeri@niaid.nih.gov

Work: 

240-627-3483

Protocol Chair

Paul Price, PhDpaul.price@nih.gov

Work: 

301-761-7835

Protocol Chair

Theresa ScoccaTheresa_Scocca@rhoworld.com

Work: 

919-595-6312